Korea Green Cross, and Jaseng oriental hospital to jointly develop natural new drugs

Published: 2003-12-15 06:57:00

Updated: 2003-12-15 06:57:00

Korea Green Cross R&D Co., an affiliated company of Korea Green Cross Corporation said that it signed with Jaseng oriental hospital a strategic joint venture in the development of natural new drugs on December 10.

KGC R&D plans to invest a total of 10 billion won for the next five years to com...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK